BioSpace News Archive

Spectroscopy®, a multimedia platform that promotes the use of spectroscopic instrumentation in applied research, environmental testing, quality control and the life sciences, is proud to announce that editorial advisory board members Howard Mark and Jerome Workman Jr. have been named winners of the 2020 New York Society for Applied Spectroscopy Gold Medal Award.

Prelude Corporation (PreludeDx™), a leader in molecular diagnostics and precision medicine for early stage breast cancer, announced today the appointment of Edwin C. Hendrick as Chief Commercial Officer.

Anthony Sallustio, DDS, was honored with the Private Practice Prosthodontist Award for the Northeast Region of the American College of Prosthodontists, covering the eastern coast of the United States from Maine to New Jersey.

Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage neuroscience company with expertise in protein misfolding, today reported financial results for the fourth quarter and full year 2019.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2019.

Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, announced today that Chris Linthwaite, President and Chief Executive Officer, will present updates on Fluidigm’s business at the following investor conferences in March:

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2019 after market close on Monday, February 24, 2020.

Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs post-market on February 19, 2020.

As previously announced on January 14, Masimo (NASDAQ: MASI) will release fourth quarter and full year 2019 financial results for the period ended December 28, 2019, after the market closes on Wednesday, February 19, 2020

CONMED Corporation announced that Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:30 a.m. ET on Wednesday, February 26, 2020 in New York, NY.